CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,208,275
- in 16 filings, $12.2M under 10b5-1 plans
Net −$12,208,275. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-14 | Callos Andrew EVP, Chief Commercial Officer | Grant or award | +32,687 | 70,350 | ||
| 2025-03-14 | Callos Andrew EVP, Chief Commercial Officer | Grant or award · Incentive Stock Option (Right to Buy) | +2,749 | 2,749 | ||
| 2025-03-14 | Callos Andrew EVP, Chief Commercial Officer | Grant or award · Non-Qualified Stock Option (Right to Buy) | +47,593 | 47,593 | ||
| 2025-03-14 | Malik Fady Ibraham EVP Research & Development | Grant or award | +39,450 | 144,844 | ||
| 2025-03-14 | Malik Fady Ibraham EVP Research & Development | Grant or award · Incentive Stock Option (Right to Buy) | +2,293 | 2,293 | ||
| 2025-03-14 | Malik Fady Ibraham EVP Research & Development | Grant or award · Non-Qualified Stock Option (Right to Buy) | +58,465 | 58,465 | ||
| 2025-03-14 | Blum Robert I President & CEO | Grant or award | +116,096 | 480,277 | ||
| 2025-03-14 | Blum Robert I President & CEO | Grant or award · Incentive Stock Option (Right to Buy) | +2,254 | 2,254 | ||
| 2025-03-14 | Blum Robert I President & CEO | Grant or award · Non-Qualified Stock Option (Right to Buy) | +176,547 | 176,547 |
Page 22 of 22 · 429 trades